Yahoo奇摩 網頁搜尋

搜尋結果

  1. Australian categorisation system and database for prescribing medicines in pregnancy have been developed by medical and scientific experts based on available evidence of risks associated with taking particular medicines while pregnant.

  2. The Australian categorisation system differs from the US FDA categorisation. The categorisation of medicines for use in pregnancy does not follow a hierarchical structure. Human data are lacking or inadequate for drugs in the B1, B2 and B3 categories. Subcategorisation of the B category is based on animal data.

  3. 其他人也問了

  4. 2022年5月26日 · Category B3Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus having been observed

  5. The Prescribing Medicines in Pregnancy database has now been updated to include the following new entries: amifampridine - pregnancy category C. amphotericin B (liposomal) - pregnancy category B2. alpelisib - pregnancy category D.

  6. Health professionals are advised that the Product Information (PI) documents for methylphenidate products have been updated with new information about use in pregnancy. The pregnancy category has now been changed from Category B3 to Category D and the

  7. 2024年5月29日 · Pregnancy category B2 Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus having been observed.

  8. 2024年3月6日 · Pregnancy category B3 Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus having been observed.